Bml Capital Management, LLC Milestone Pharmaceuticals Inc. Transaction History
Bml Capital Management, LLC
- $149 Billion
- Q1 2024
A detailed history of Bml Capital Management, LLC transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Bml Capital Management, LLC holds 606,145 shares of MIST stock, worth $1.05 Million. This represents 0.73% of its overall portfolio holdings.
Number of Shares
606,145
Previous 442,352
37.03%
Holding current value
$1.05 Million
Previous $739 Million
46.87%
% of portfolio
0.73%
Previous 0.56%
Shares
5 transactions
Others Institutions Holding MIST
# of Institutions
48Shares Held
31.4MCall Options Held
3.3KPut Options Held
3.5K-
Black Rock Inc. New York, NY4.97MShares$8.65 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.26MShares$5.67 Million0.09% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.86MShares$4.97 Million0.0% of portfolio
-
Alta Fundamental Advisers LLC New York, NY2.37MShares$4.13 Million2.21% of portfolio
-
Lion Point Capital, LP New York, NY2.3MShares$4 Million2.63% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $52.2M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...